Members of FDA Risk Communications Advisory Committee.
Wyeth R&D senior execs meet with FDA drug review managers in September 2007.
Oncologists, an ex-Congresswoman, and a former Bush Administration health policy advisor met with FDA senior managers (including Commissioner von Eschenbach) in October before FDA decidied to support the Centers for Medicare and Medicaid Services in its effort to restrict use of EPO for chemotherapy patients.
Howard Heinz University Professor
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
